Voxzogo 1.2 mg powder and solvent for solution for injection, powder and solvent for solution for injection, Voxzogo 0.56 mg powder and solvent for solution for injection
111-303
Phase 3 small_molecule active
Quick answer
Voxzogo 1.2 mg powder and solvent for solution for injection, powder and solvent for solution for injection, Voxzogo 0.56 mg powder and solvent for solution for injection for Hypochondroplasia is a Phase 3 program (small_molecule) at BioMarin International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioMarin International Limited
- Indication
- Hypochondroplasia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active